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Abstract
Background
Blood pressure (BP) is a complex, multifactorial clinical outcome driven by genetic suscepti-
bility, behavioral choices, and environmental factors. Many molecular mechanisms have
been proposed for the pathophysiology of high BP even as its prevalence continues to grow
worldwide, increasing morbidity and marking it as a major public health concern. To address
this, we evaluated miRNA profiling in blood leukocytes as potential biomarkers of BP and
BP-related risk factors.
Methods
The Beijing Truck Driver Air Pollution Study included 60 truck drivers and 60 office workers
examined in 2008. On two days separated by 1–2 weeks, we examined three BP measures:
systolic, diastolic, and mean arterial pressure measured at both pre- and post-work exams
for blood NanoString nCounter miRNA profiles. We used covariate-adjusted linear mixed-
effect models to examine associations between BP and increased miRNA expression in
both pooled and risk factor-stratified analyses.
Results
Overall 43 miRNAs were associated with pre-work BP (FDR<0.05). In stratified analyses dif-
ferent but overlapping groups of miRNAs were associated with pre-work BP in truck drivers,
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high-BMI participants, and usual alcohol drinkers (FDR<0.05). Only four miRNAs were
associated with post-work BP (FDR<0.05), in ever smokers.
Conclusion
Our results suggest that many miRNAs were significantly associated with BP in subgroups
exposed to known hypertension risk factors. These findings shed light on the underlying
molecular mechanisms of BP, and may assist with the development of a miRNA panel for
early detection of hypertension.
Introduction
Hypertension (HTN), defined as systolic blood pressure (SBP) above 140 mmHg or diastolic
blood pressure (DBP) above 90 mmHg, is a major public health concern worldwide [1, 2]. Despite
our understanding of the disease and availability of treatments, 80 million adults in the US [3] as
well as 266 million adults in China [4] suffer from HTN, indicating a substantial unrelieved public
health burden. With primary prevention efforts (e.g., the DASH diet) [5, 6] largely unsuccessful
in populations in recent decades, secondary prevention through earlier disease detection may aid
reducing HTN-related health disparities and economic burdens. In particular analyses of whole
blood have found shifts in environment-induced gene expression that presage systemic pro-
inflammatory processes [7–9] and can predict future cardiovascular disease risk [10]. Greater
insight into molecular mechanisms related to elevated blood pressure (EBP), a physiological event
related to clinical HTN, can assist in addressing its current unmet public health burden.
Since EBP results from a set of complex genetic, pathophysiological, and environmental fac-
tors [11] post-translational modifications are a natural candidate for biomarker studies of
hypertension risk factors and early detection [11–13]. Post-translational modifications to gene
expression include DNA methylation, histone modification, and microRNAs (miRNAs), and
can all functionally alter gene expression without changing the underlying DNA sequence [13,
14]. miRNAs are small (20–24 base) nucleotides that induce messenger RNA (mRNA) cleav-
age or reduce translation to regulate gene expression [15–18], thus having a potentially pro-
found impact on diseases including HTN. Studies have connected handfuls of miRNAs such
as the miRNA130/301 family [19] to HTN via pathways such as promoting vasoconstriction
and thus increasing pulmonary BP [20]. Due to these associations and the stability of miRNAs,
researchers have previously suggested their potential use as biomarkers for HTN [19–22].
However, many of the specific biological mechanisms underlying the relationship between
miRNAs and EBP or EBP-related risk factors have yet to be elucidated.
Our group previously reported that traffic-related exposure to ambient PM10 (particulate matter
10 μm) affects blood pressure (BP) [23], and that this exposure was associated with the expres-
sion of human miRNAs [24]. As an additional component to this research we investigated miRNA
profiles in blood leukocytes and their relation to BP in 120 workers in urban Beijing [25]. Because
evidence suggests that BP varies throughout the day [26, 27], our objective was to explore the sepa-
rate relationships between BP measured pre- and post-work and miRNA expression levels.
Materials and methods
Study participants
The Beijing Truck Driver Air Pollution Study was conducted between June 15 and July 27,
2008 in two groups highly exposed to air pollution: 60 truck drivers and 60 office workers [23].
BP and miRNAs in blood
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Both of these occupation groups were matched by sex, smoking status, education, and age (+5
years). Each participant was examined twice each on two days one to two weeks apart, for a
total of two examination days and four examinations per participant to allow for short-term
variations in BP. Blood samples were collected at the end of each examination day only, allow-
ing for two miRNA measures per participant (240 total). We used a self-administered ques-
tionnaire to collect detailed information on demographics and lifestyle as well as time-varying
factors (e.g., smoking) which were self-reported both for past patterns and day of examination
data (i.e., smoking status and number of cigarettes smoked on the exam day respectively).
Daily temperature and dew point data for Beijing were obtained from the National Oceanic
and Atmospheric Administration [28]. Individual written informed consent was obtained
from all participants prior to enrollment in the study. Institutional Review Board or equivalent
approval at the participating institution (i.e., Harvard School of Public Health, Northwestern
University, and Peking University Health Science Center) was obtained prior to study partici-
pant recruitment.
miRNA measurement
A total of 240 peripheral blood samples from 120 participants were collected in PAXgene
Blood RNA Tubes (Qiagen, Valencia, California) at each post-work exam. Detailed data pro-
cessing procedures can be found in the Supplemental Materials. Briefly, total RNA was
extracted using the PAXgene Blood-RNA Kit Qiagen-763134 (Qiagen, Valencia, California).
All samples had optical density ratios of 280/2601.9 and 260/2301.8. RIN (RNA Integrity
Number) scores, thus showing excellent RNA quality (mean: 8.3±0.9). We profiled miRNAs
using NanoStringnCounter-miRNA expression analysis (NanoString Technologies, Seattle,
Washington). The nCounter miRNA data were also confirmed through cross-platform valida-
tion in 20 randomly-selected study samples using the TaqManOpenArray Real-Time PCR
Plates (Life Technologies, Carlsbad, California) on the QuantStudio 12K Flex Real-Time PCR
System. The average Pearson correlation coefficient was 0.73 (0.63–0.79) between the two plat-
forms, thus confirming the robustness of nCounter. The raw and processed miRNA data have
been deposited into the NCBI Gene Expression Omnibus (accession number GSE63087).
miRNA expression data were processed and obtained as described previously [24]. After dis-
carding miRNAs that were not detectable in over 90% of samples, 166 miRNAs (including
seven viral miRNAs) were retained for analysis.
Blood pressure measurements
The seated BP of each individual was measured by a trained research assistant at each exam-
ination after a full five minutes of rest. Per the American Heart Association’s standardized
measurement protocol[29], BP was measured via mercury sphygmomanometer on the right
arm using an appropriate cuff size and three readings separated by at least one minute
taken. BP was calculated from the average of the second and third readings and rounded up
to the nearest whole number. Mean arterial pressure (MAP) was estimated by adding 1/3 of
the difference between systolic blood pressure (SBP) and diastolic blood pressure (DBP) to
the DBP value.
Statistical analysis
For our descriptive analysis we used mixed-effects linear regression models to assess each
of the three BP measures (pre- and post-work) across categories of independent variables
(continuous variables were categorized according to the distribution of the data) while
incorporating repeated measures data. We also conducted t-tests to compare pre- and
BP and miRNAs in blood
PLOS ONE | DOI:10.1371/journal.pone.0173550 March 9, 2017 3 / 13
post-work BP measures, and generated MA plots of describing differential miRNA expres-
sion by pre-work BP level. Next we used mixed-effects linear regression models to evaluate
the associations of miRNAs with BP in the entire sample (pooled analysis) accounting for
repeated measures. We also conducted sensitivity analyses to explore the effect of using the
change from pre- to post-work in each BP measurements as an additional outcome, and
separate analyses of each visit.
Next, for our stratified analyses we identified gender, BMI, smoking status, and alcohol
consumption as EBP risk factors based on our descriptive analysis (variables associated with
BP at p<0.05). We performed stratified analyses on these risk factors as well as occupation
(based on our prior work finding differential pollutant exposure by occupation [30]) to explore
potential differential miRNAs expression. For the BMI-stratified analysis we selected a cut-
point of 23kg/m2 based on WHO recommendations for BMI measurement and intervention
in Asian populations [31]. For the pooled analysis, the regression model was adjusted for
covariates including age, occupation, gender, BMI, smoking status, number of cigarettes
smoked on examination day, examination date, alcohol consumption, work hours per week,
and outdoor temperature and dew point on the examination day. In the stratified analyses, we
adjusted for all variables listed above except the stratification variable (occupation, sex, BMI,
smoking status, and usual alcohol drinking). Because our previous findings suggested that air
pollutant exposures impact BP [23], we also adjusted for personal particulate matter10 μm
(PM10). Since miRNA data was log-2 transformed we presented the results as unit change in
mmHg of BP per each two-fold increase in miRNA. All statistical tests were two-sided, and BP
changes with a Benjamini-Hochberg false discovery rate (FDR) <5% [32] were considered sta-
tistically significant. All analyses were performed using SAS 9.4 (Cary, NC).
Results
Characteristics of study participants and blood pressure measurements
Blood pressure measures before and after work by participant characteristics are summarized
in Table 1 and Table 2, respectively. Briefly SBP, DBP, and MAP all significantly differed across
gender, BMI, smoking status, and alcohol consumption at both times of day. In addition, all
three post-work BP measures varied across temperature, and SBP by dew point, on exam days.
No BP measures significantly varied across age, occupation, or calendar day of exam. SBP was
significantly higher at the post-work exam compared to pre-work (p<0.01), but DBP and
MAP were not (p = 0.69 and 0.45, respectively) (S1 Fig).
Pooled analyses
Pre-work BP measured was significantly associated with post-work miRNA expression
(Table 3). We identified 43 miRNAs whose levels were associated with one or more BP mea-
sures: 32 with SBP and 42 with MAP (Table 3, S1 and S2 Tables). No associations were identi-
fied for DBP. Fig 1A and 1B show miRNA associations with pre-work SBP and MAP,
respectively, arranged by magnitude of unit difference in mmHg per each two-fold increase in
miRNA. We did not find any significant associations of miRNA expression levels with post-
work BP, nor with BP change from pre- to post-work measures. Analyzing each examination
day separately attenuated the statistical significance of all findings (due to loss of sample size),
but in general results were similar in direction and magnitude to those of our pooled, mixed-
model analysis (data available upon request). Our MA plots of pre-work BP can also be found
in our supplementary materials (S2 Fig).
BP and miRNAs in blood
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Stratified analyses
For the stratified analyses we found significant associations between miRNAs and pre-work
BP in truck drivers, high-BMI participants, and usual alcohol drinkers (Table 3, S1 and S2
Tables). In truck drivers 39 miRNAs were associated with SBP, of which seven were unique to
the truck driver stratum. In high-BMI participants 60 miRNAs were associated with SBP
Table 1. Pre-work blood pressure by participant characteristics.
Variables N(%) Systolic Blood Pressure Diastolic Blood Pressure Mean Arterial Pressure
Meana SEa p-valueb Meana SEa p-valueb Meana SEa p-valueb
Group, n (%)
Office workers 120 (50%) 111.5 1.5 0.14 77.7 1.1 0.26 89.0 1.2 0.19
Truck drivers 120 (50%) 114.6 1.5 79.5 1.1 91.2 1.2
Sex
Female 80 (33.33%) 104.9 1.6 <0.01 73.6 1.3 <0.01 84.1 1.3 <0.01
Male 160 (66.67%) 116.8 1.1 81.0 0.9 92.9 0.9
Age (Quartile)
Q1 [18–27 years] 60 (25%) 112.1 2.1 0.39 77.7 1.6 0.12 89.2 1.7 0.15
Q2 [28–32 years] 62 (25.83%) 111.6 2.0 76.5 1.6 88.2 1.7
Q3 [33–37 years] 58 (24.17%) 112.6 2.1 78.7 1.6 90.0 1.7
Q4 [38–46 years] 60 (25%) 116.2 2.1 81.8 1.6 93.4 1.7
BMI
23 kg/m2 120 (50%) 108.2 1.3 <0.01 74.7 1.0 <0.01 85.9 1.1 <0.01
>23 kg/m2 120 (50%) 118.6 1.3 82.6 1.0 94.6 1.1
Smoking habits
Never smoked 138 (57.5%) 109.7 1.3 <0.01 76.8 1.1 0.01 87.8 1.1 <0.01
Ever smoked 102 (42.5%) 117.4 1.5 80.9 1.2 93.1 1.3
Usual alcohol drinking
Yes 90 (37.5%) 110.0 1.2 <0.01 76.7 1.0 <0.01 87.9 1.0 <0.01
No 150 (62.5%) 117.8 1.6 81.6 1.3 93.7 1.3
Temperature c
Low [20–25 ˚C] 110 (35.83%) 112.9 1.2 0.87 78.7 1.0 0.78 90.1 1.0 0.94
High [26–29 ˚C] 130 (54.17%) 113.1 1.1 78.5 0.9 90.1 0.9
Dew point c
Low [16–20 ˚C] 107 (44.58%) 114.1 1.2 0.07 78.6 1.0 0.99 90.4 1.0 0.50
High [21–24 ˚C] 133 (55.42%) 112.2 1.1 78.6 0.9 89.9 0.9
Day of the week
Monday 35 (14.58%) 112.1 1.6 0.10 79.0 1.4 0.46 90.1 1.3 0.28
Tuesday 31 (12.92%) 111.6 1.8 76.6 1.5 88.2 1.5
Wednesday 29 (12.08%) 114.9 1.9 78.7 1.6 90.7 1.6
Thursday 35 (14.58%) 110.9 1.8 76.7 1.5 88.2 1.5
Friday 36 (15%) 112.0 1.9 79.3 1.6 90.2 1.5
Saturday 34 (14.17%) 113.1 2.0 79.0 1.7 90.6 1.7
Sunday 40 (16.67%) 117.0 1.7 80.3 1.4 92.5 1.4
a Means and standard error of blood pressure and heart rate measured on two examination days were estimated by marginal means and corresponding
standard error from mixed-effects regression models.
b p-values were calculated using mixed-effects regression models.
c Temperature and dew point were measured on the study examination day.
doi:10.1371/journal.pone.0173550.t001
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including 18 miRNAs that were unique to participants in the high-BMI stratum. In usual alco-
hol drinkers 10 miRNAs were associated with MAP, including one miRNA unique to the
usual alcohol drinkers stratum. For the post-work BP measures we identified four miRNAs
associated with MAP in ever smokers (S3 Table), all of which were unique to the stratum of
ever smokers.
Table 2. Post-work blood pressure by participant characteristics.
Variables N(%) Systolic Blood Pressure Diastolic Blood Pressure Mean Arterial Pressure
Meana SEa p-valueb Meana SEa p-valueb Meana SEa p-valueb
Group, n (%)
Office workers 120 (50%) 115.3 1.5 0.66 77.8 1.1 0.10 90.3 1.2 0.23
Truck drivers 120 (50%) 116.3 1.5 80.3 1.1 92.3 1.2
Sex
Female 80 (33.33%) 107.8 1.7 <0.01 74.2 1.2 <0.01 85.4 1.3 <0.01
Male 160 (66.67%) 119.9 1.2 81.6 0.9 94.2 0.9
Age (Quartile)
Q1 [18–27 years] 60 (25%) 116.9 2.2 0.83 78.0 1.5 0.40 90.9 1.7 0.71
Q2 [28–32 years] 62 (25.83%) 114.8 2.2 77.6 1.5 90.0 1.6
Q3 [33–37 years] 58 (24.17%) 114.8 2.2 80.2 1.5 91.7 1.7
Q4 [38–46 years] 60 (25%) 116.8 2.2 80.5 1.5 92.6 1.7
BMI
23 kg/m2 120 (50%) 111.6 1.4 <0.01 75.5 1.0 <0.01 87.5 1.1 <0.01
>23 kg/m2 120 (50%) 120.0 1.4 82.6 1.0 95.0 1.1
Smoking habits
Never smoked 138 (57.5%) 112.6 1.4 <0.01 77.6 1.0 0.02 89.2 1.1 <0.01
Ever smoked 102 (42.5%) 120.1 1.6 81.1 1.1 94.0 1.2
Usual alcohol drinking
Yes 90 (37.5%) 113.0 1.3 <0.01 77.1 0.9 <0.01 89.0 1.0 <0.01
No 150 (62.5%) 120.6 1.7 82.4 1.2 95.1 1.3
Temperature c
Low [20–25 ˚C] 110 (35.83%) 117.3 1.2 0.01 80.3 0.9 0.01 92.5 0.9 <0.01
High [26–29 ˚C] 130 (54.17%) 114.6 1.2 78.1 0.8 90.2 0.9
Dew point c
Low [16–20 ˚C] 107 (44.58%) 117.1 1.2 0.02 79.2 0.9 0.86 91.8 1.0 0.30
High [21–24 ˚C] 133 (55.42%) 114.8 1.2 79.0 0.8 90.9 0.9
Day of the week
Monday 35 (14.58%) 115.7 1.7 0.73 78.0 1.3 0.54 90.6 1.3 0.59
Tuesday 31 (12.92%) 115.6 1.8 77.4 1.4 90.0 1.4
Wednesday 29 (12.08%) 116.9 1.9 79.1 1.5 91.5 1.5
Thursday 35 (14.58%) 116.9 1.8 80.8 1.4 93.0 1.4
Friday 36 (15%) 113.2 1.9 78.7 1.5 90.2 1.5
Saturday 34 (14.17%) 116.1 2.0 79.0 1.6 91.4 1.6
Sunday 40 (16.67%) 116.4 1.7 80.1 1.4 92.0 1.4
a Means and standard error of blood pressure and heart rate measured on two examination days were estimated by marginal means and corresponding
standard error from mixed-effects regression models.
b p-values were calculated using mixed-effects regression models.
c Temperature and dew point were measured on the study examination day.
doi:10.1371/journal.pone.0173550.t002
BP and miRNAs in blood
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Discussion
To our knowledge this study is the first to evaluate miRNA profiling from blood leukocytes in
relation to BP among a cohort of Chinese workers. We observed that both pre- and post-work
SBP, DBP, and MAP were all higher in participants that were male, had higher BMI, or were
smokers; all traditional risk factors of HTN [33]. Our pooled analysis also revealed 43 miRNAs
associated with one or more BP measures but only at the pre-work exams. The stratified analy-
ses showed varied significant associations between miRNAs and pre-work BP measures by
strata of subject characteristics including occupation, BMI, and usual alcohol drinking, as well
as only ever-smokers had a panel of miRNAs significantly associated with post-work BP.
Previous studies have related some miRNAs to molecular changes involved with HTN or
cardiovascular diseases. For instance, we identified miR-151-5p as one of the most significant
positive miRNA-BP associations in our pooled analysis as well as the strata of truck drivers,
high-BMI participants, and usual alcohol drinkers (Supplemental Tables 1–2). A previous
study linked down-regulation of miR-151-5p to ischemic arrhythmia [34], while a second
linked increased miR-151-5p expression to aneurysm prevalence [35]. As both of these out-
comes are potentially linked to HTN, miR-151-5p could be an early sign of HTN and thus a
potentially useful early detection biomarker for HTN and/or a range of cardiovascular dis-
eases. For another primary result of our pooled analysis (and the stratum of truck drivers),
miR-22, systemic administration of miR-22 antagomirs reduced BP in spontaneously hyper-
tensive rats [36], suggesting its potential therapeutic value for hypertensive patients. Our find-
ings add to the evidence of a role for these miRNAs in the pathophysiology of HTN.
miRNA expression levels can be affected by a large number of factors and regulatory pro-
cesses [37]. The distinct groups of miRNAs associated with EBP within strata of various subject
characteristics therefore suggest potential molecular pathways for BP-related risk factors. For
instance, miR-425 was found to be positively associated with BP in our high-BMI group (and
Table 3. Number of miRNAs associated with BP measured pre- and post-work, in all participants and by strata of occupation and characteristics
at FDR <0.05.
Pre-Work Post-Work
Any BP
Measure
All BP
Measures
Stratum-Specific
miRNAs
Any BP
Measure
All BP
Measures
Stratum-Specific
miRNAs
All Participants 43 0 N/A 0 0 N/A
Occupation
Office workers 0 0 0 0 0 0
Truck drivers 39 0 7 0 0 0
Sex
Female 0 0 0 0 0 0
Male 0 0 0 0 0 0
BMI
23kg/m2 (Low) 0 0 0 0 0 0
>23kg/m2 (High) 60 0 17 0 0 0
Smoking Status
Never smoked 0 0 0 0 0 0
Ever smoked 0 0 0 4 0 4
Usual alcohol
drinking
No 0 0 0 0 0 0
Yes 10 0 1 0 0 0
doi:10.1371/journal.pone.0173550.t003
BP and miRNAs in blood
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Fig 1. miRNAs associated with pre-work blood pressure changes in pooled analysis. Significant
miRNAs associated with (A) SBP, and (B) MAP at FDR<5% in the pooled analysis.
doi:10.1371/journal.pone.0173550.g001
BP and miRNAs in blood
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neither our pooled analysis nor our other strata), and has been linked to blood pressure regula-
tion through salt homeostasis (preventing its binding with appropriate gene) [38]. This finding
may therefore be a biomarker of higher salt consumption in the high-BMI stratum. Another
example in our high-BMI stratum, miR-208b, regulates the expression of slow myosin and
thus plays an important role in both exercising and stress-response, and both of which are
involved in the progression of EBP to HTN [39, 40]. These and other miRNAs identified in
our high-BMI stratum should be examined in future research for associations with salt intake
or other lifestyle factors (particularly diet) known to be associated with both BMI and HTN.
These results could indicate miRNA involvement in the well-characterized relationship
between high BMI and HTN.
Furthermore several miRNAs identified as significant in both our pooled and stratified
analyses have been associated with pulmonary hypertension and/or traditional cardiovascular
risk factors in prior epidemiological studies. miR-96 has been previously associated with pul-
monary hypertension via 5-HT1BR expression; [41] while we lacked the data necessary to
explore this pathway in our analysis, we also found miR-96 was significantly associated with
BP measures. Bye et al. [42] also found that circulating miR-21 in men was negatively associ-
ated with aerobic fitness (itself associated with BP) while Wei et al. [22] found that miR-21 was
associated with pulmonary hypertension along with two of our other significant results (miRs
191and 208b). While our results are based on miRNA expression in blood leukocytes, and are
therefore not necessarily directly related to the circulating miRNAs reported in the literature,
the overlap in these results (particularly given the racial differences between our cohort and
those reported previously) are suggestive of common pathways in the interplay between the
traditional risk factors of occupation, BMI, and smoking status and EBP development that
should be explored in the future.
The fact that the majority of our findings are present only in the pre-work rather than the
post-work BP measurements is curious, but perhaps unsurprising. BP is known to vary during
the day [26, 27], and a morning surge in BP is a risk factor for cardiovascular disease and other
adverse health outcomes [43]. A morning BP surge has also been associated with BP-related
risk factors, including several identified as associated with specific pools of miRNAs in our
study (e.g., alcohol use and smoking) [43]. Conversely, some attempts to replicate these links
with a morning blood pressure surge have been unsuccessful with poor reproducibility and
various subject-specific factors (e.g., sleep quality) cited as potentially confounding factors
[44]. Given that cardiovascular events also tend to occur more frequently and BP in general
tends to be higher after awakening [45], measurements of BP after this time (e.g., to account
for between-subject sleep quality) may be a more reproducible health predictor. The fact that
most of our stratified analyses were significant only at the pre-work measurement also raises
the possibility that other unmeasured confounders occurring during the work day (e.g., diet,
stress, physical activity) affect BP measurements, and that later studies of post-translational
gene expression modification in HTN would be best served by measuring BP-related outcomes
early in the day.
Our study is subject to a number of limitations. Our small sample size limited our ability to
make statistical inferences, and cannot establish temporality. The high air pollution exposure
in our population could attenuate associations that operate on competing molecular pathways.
We attempted to address this limitation by controlling for air pollution exposure in our study,
but nonetheless our results may have false negatives. In addition data on white blood cell
counts and abundancies were not collected in this cohort, which limits our ability to draw bio-
logical or mechanistic insight from these findings. We attempted to minimize potential con-
founding due to short-term changes in blood cell abundancies[46] by employing a repeated-
measures, matched study design with mixed effect models. As intra-individual miRNA and
BP and miRNAs in blood
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gene expression profiles are relatively stable over short (<1 year) time scales [47], any short-
term inter- or intra-individual changes in blood composition are likely to be very small and
unlikely to change our results substantively. Exploring miRNAs as potential blood-based bio-
markers will still facilitate subsequent research in cohorts without contemporaneous blood
composition data, and prior biomarker studies that did not include it [30, 48–53]. Finally, all
of our significant associations were in the same direction, a potentially unusual finding. This
could be due to residual confounding, or ‘morning surge’ in BP discussed above. However
given the many miRNAs we simultaneously analyzed, there is also the possibility that this is a
new finding. If miRNAs are largely up-regulated in response to increasing BP, global miRNA
levels could be a useful biomarker. Further research in diverse populations using a similar,
repeated measures design should be conducted to further explore these possibilities.
Despite these limitations, our study has notable strengths. The homogeneity of our popula-
tion allows a limited control of certain unmeasured confounding factors: a small, racially-
homogenous group living in the same area would be expected to have similar dietary and envi-
ronmental exposures, serving as a crude form of matching that could reduce the effects of a
variety of unmeasured confounders. In addition, our use of multiple measurements for both
BP and miRNAs allowed us to account for short-term variations in both factors, making our
results more likely to reflect trends that are of greater public health relevance.
Our results reveal miRNAs significantly associated with BP, many of them exclusive to
strata known to be high-risk for HTN. Future research in diverse cohorts is needed to validate
these findings, but if confirm these results may shed light on the development of a miRNA
panel for early detection of HTN (and potentially other cardiovascular outcomes) in the future
and highlighting the potential for miRNA-mediated risk factors for HTN and other cardiovas-
cular diseases. Future research should follow these results using larger, more representative
populations to identify specific pathways in humans linking the functions of these miRNAs to
their role in elevating BP.
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